idaciohcp.com - For Health Care Professionals | IDACIO® (adalimumab-aacf)

Description: Learn about IDACIO® (adalimumab-aacf), an FDA-approved biosimilar for HUMIRA® (adalimumab) made by Fresenius Kabi. See safety, dosing, & full prescribing info.

Example domain paragraphs

Idacio ® (adalimumab-aacf) injection, for subcutaneous use, is an FDA-approved biosimilar of Humira ® (adalimumab)

*Not commercially available before July 2023.

Patients treated with IDACIO ® (adalimumab-aacf) are at increased risk for developing serious infections that may lead to hospitalization or death. Most patients who developed these infections were taking concomitant immunosuppressants such as methotrexate or corticosteroids.

Links to idaciohcp.com (1)